Strs Ohio Seres Therapeutics, Inc. Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$3.5 - $7.2 $301,350 - $619,920	-86,100 Reduced 47.89%	93,700 $601,000
Q2 2022 Jul 25, 2022	BUY	$2.7 - $7.62 $207,900 - $586,740	77,000 Added 74.9%	179,800 $616,000
Q1 2022 Apr 21, 2022	BUY	$6.3 - $8.84 $25,830 - $36,244	4,100 Added 4.15%	102,800 $731,000
Q4 2021 Jan 24, 2022	BUY	$6.02 - $11.43 $594,174 - $1.13 Million	98,700 New	98,700 $822,000
Q1 2021 Apr 23, 2021	SELL	$17.66 - $28.92 $104,194 - $170,628	-5,900 Closed	0 $0
Q3 2020 Dec 14, 2020	BUY	$3.74 - $28.74 $20,196 - $155,196	5,400 Added 1080.0%	5,900 $167,000
Q3 2017 Oct 23, 2017	BUY	$12.81 - $16.85 $6,405 - $8,425	500	500 $8,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.